27 computing-"https:"-"https:"-"https:"-"The-University-of-Manchester" Fellowship positions at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
We are seeking a computational glycobiologist to join a multidisciplinary project developing next-generation enzymatic tools for antibody glycoengineering. The role will focus on applying state
-
pressing challenges. We are seeking a Research Fellow in Molecular Dynamics and Computational Chemistry to join the School of Electronics and Computer Science (ECS) at the University of Southampton
-
The Faculty of Medicine Genomic Informatics Group invites applications for a 3-year full time fixed-term postdoctoral position of Research Fellow or Senior Research Fellow in Genomic Informatics to
-
) Country United Kingdom Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a
-
We are looking to appoint a postdoctoral researcher with experience and expertise in nanoelectronic device fabrication, to be based in the School of Electronics and Computer
-
of Electronics and Computer Science at the University of Southampton as part of the group of Prof. Kees de Groot and Dr Ruomeng Huang. This postdoctoral fellowship is part of the EXPRESS (Exploiting Single Source
-
for Selective Absorbers. Your primary role will be to undertake theoretical and computational research on hyperuniform disordered photonic materials for frequency-selective solar-thermal absorbers based on metal
-
biggest challenges. We are seeking a Research Fellow in Liquid Metal Artificial Enzymes to join the School of Electronics and Computer Science (ECS) at the University of Southampton. The successful
-
programme, Deep Molecular Phenotyping of Metastatic Breast Cancer. This ambitious, interdisciplinary project aims to generate an integrated, multi-omic understanding of secondary (metastatic) breast cancer
-
postdoctoral scientist to work on our Blood Cancer UK-funded programme developing next-generation, off-the-shelf immunotherapies for acute myeloid leukaemia (AML). This three-year project will harness cytotoxic